These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23928759)

  • 1. Q&A: Eric Winer on neoadjuvant clinical trials.
    Winer E
    Cancer Discov; 2013 Aug; 3(8):832. PubMed ID: 23928759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant endocrine therapy for breast cancer: medical perspectives.
    Ellis MJ
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4388s-4391s; discussion 4411s-4412s. PubMed ID: 11916229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer.
    Chang HR
    Cancer; 2010 Jun; 116(12):2856-67. PubMed ID: 20564392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant endocrine therapy for breast cancer: more questions than answers.
    Ellis MJ
    J Clin Oncol; 2005 Aug; 23(22):4842-4. PubMed ID: 15998901
    [No Abstract]   [Full Text] [Related]  

  • 5. Review of the development of letrozole and its use in advanced breast cancer and in the neoadjuvant setting.
    Bhatnagar AS
    Breast; 2006 Feb; 15 Suppl 1():S3-13. PubMed ID: 16500235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant/primary chemotherapy in cancer treatment: what advantage?
    Wynendaele W; van Oosterom AT
    Forum (Genova); 1999; 9(3):212-21. PubMed ID: 10504169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating trastuzumab into the neoadjuvant treatment of HER2-overexpressing breast cancer.
    Montemurro F; Aglietta M
    Clin Breast Cancer; 2005 Apr; 6(1):77-80. PubMed ID: 15899075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks.
    Buchholz TA; Hunt KK; Whitman GJ; Sahin AA; Hortobagyi GN
    Cancer; 2003 Sep; 98(6):1150-60. PubMed ID: 12973838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based neoadjuvant endocrine therapy for breast cancer.
    Dienstmann R; Bines J
    Clin Breast Cancer; 2006 Oct; 7(4):315-20. PubMed ID: 17092398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interview with Loren D Walensky.
    Walensky LD
    Future Med Chem; 2012 Aug; 4(12):1537-9. PubMed ID: 22917243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chemotherapy for breast cancer.
    Buzdar AU
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):212, 215. PubMed ID: 16163183
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sentinel lymph node and neoadjuvant therapy in breast cancer: searching for the best scenario].
    Solá M; Fraile M
    Rev Esp Med Nucl; 2010; 29(6):316-8. PubMed ID: 21055516
    [No Abstract]   [Full Text] [Related]  

  • 13. Speeding discoveries with neoadjuvant studies.
    Cancer Discov; 2012 Apr; 2(4):294. PubMed ID: 22576193
    [No Abstract]   [Full Text] [Related]  

  • 14. Predicting locoregional recurrence after neoadjuvant chemotherapy in patients with breast cancer.
    Mamounas TP
    Clin Adv Hematol Oncol; 2013 Mar; 11(3):175-7. PubMed ID: 23598985
    [No Abstract]   [Full Text] [Related]  

  • 15. Neoadjuvant endocrine therapy in breast cancer.
    Abrial C; Mouret-Reynier MA; Curé H; Feillel V; Leheurteur M; Lemery S; Le Bouëdec G; Durando X; Dauplat J; Chollet P
    Breast; 2006 Feb; 15(1):9-19. PubMed ID: 16230013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sentinel lymph node and neoadjuvant therapy in breast cancer].
    Muñoz M; Pahisa J; Xavier Caparrós F; Vidal-Sicart S
    Rev Esp Med Nucl; 2010; 29(6):319-20. PubMed ID: 21055517
    [No Abstract]   [Full Text] [Related]  

  • 17. Taxanes in the treatment of early breast cancer.
    Ring AE; Ellis PA
    Cancer Treat Rev; 2005 Dec; 31(8):618-27. PubMed ID: 16266787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
    Berry J
    Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy in breast cancer.
    Charfare H; Limongelli S; Purushotham AD
    Br J Surg; 2005 Jan; 92(1):14-23. PubMed ID: 15635596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new concept.
    Iwata H
    Breast Cancer; 2011 Apr; 18(2):92-7. PubMed ID: 21140250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.